Key result
Avocado oil lowers LDL, triglycerides, and hs-CRP without altering HDL in high-sucrose diet models.
The purpose of this study was to evaluate the effects of avocado oil administration on biochemical markers of cardiovascular risk profile in rats with metabolic changes induced by sucrose ingestion. Twenty-five rats were divided into five groups: a control group (CG; basic diet), a sick group (MC; basic diet plus 30% sucrose solution), and three other groups (MCao, MCac, and MCas; basic diet plus 30% sucrose solution plus olive oil and avocado oil extracted by centrifugation or using solvent, resp.). Glucose, total cholesterol, triglycerides, phospholipids, low- and high-density lipoproteins (LDL, HDL), very low-density lipoprotein (VLDL), lactic dehydrogenase, creatine kinase, and high sensitivity C-reactive protein concentration were analyzed. Avocado oil reduces TG, VLDL, and LDL levels, in the LDL case significantly so, without affecting HDL levels. An effect was exhibited by avocado oil similar to olive oil, with no significant difference between avocado oil extracted either by centrifugation or solvent in myocardial injury biochemical indicators. Avocado oil decreased hs-CRP levels, indicating that inflammatory processes were partially reversed. These findings suggested that avocado oil supplementation has a positive health outcome because it reduces inflammatory events and produces positive changes in the biochemical indicators studied, related to the development of metabolic syndrome.
No takes yet. Share an insight, caveat, or question.
Carvajal‐Zarrabal et al. (2014) studied Sucrose-induced metabolic changes (rat model) (n=25). Avocado oil (extracted by centrifugation or solvent) vs. Basic diet alone, basic diet plus 30% sucrose, or basic diet plus 30% sucrose and olive oil was evaluated on Biochemical markers of cardiovascular risk profile (glucose, total cholesterol, TG, phospholipids, LDL, HDL, VLDL, LDH, CK, hs-CRP). Avocado oil supplementation in rats fed 30% sucrose significantly reduced LDL and decreased TG, VLDL, and hs-CRP levels without affecting HDL.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: